J&amp;J eyes Guidant?
506558
Johnson &amp; Johnson is in advanced talks to buy cardiovascular device maker Guidant Corp. for more than $24 billion, a newspaper report said Tuesday.
91019
Johnson &amp; Johnson, the pharmaceutical and health care giant, has announced an agreement to buy Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, for $25.4 billion.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to
182817
Drug giant Johnson & Johnson agrees to buy Guidant Corp, a key player in the heart technology market, for $25.4bn.
420803
Johnson &amp; Johnson has agreed to buy Guidant Corp. for $25.4 billion in cash and stock, the companies said on Wednesday, giving the healthcare products maker a foothold
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
511136
J&J gets dragged down by restructuring charges.
667986
U.S. stocks were little changed on  Tuesday, with oil prices dropping below $42 a barrel helping to  support markets, but Johnson & Johnson JNJ.N put pressure on  the Dow following a report of a possible $24 billion takeover  of cardiovascular device maker Guidant Corp. GDT.N.
97019
Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, an Indianapolis-based medical device maker, for more than $24 billion, executives close to the talks said Monday.
560518
New York (dpa) - Health-care conglomerate Johnson &amp; Johnson is in advanced negotiations to buy defibrillator maker Guidant Corp.
341615
Johnson &amp; Johnson&#39;s$25.4bn purchase of Guidant, a medical device maker, will give the big US medical group a range of fast-growing products that manage patients&#39; heart rhythms, a move that will shake up the US medical device industry.
179502
Shares of medical device maker Guidant  Corp.GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
646222
The anticipated merger of Guidant Corp. and Johnson &amp; Johnson could give an unintended boost to Boston Scientific Corp. if Guidant's drug-coated stent launch is delayed, said analysts looking at the implications of a potential deal.
312826
Johnson &amp; Johnson announced that it will acquire Guidant Corp., one of the world&#39;s top makers of cardiac devices, for $25.4 billion US.
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
437703
Health care giant Johnson &amp; Johnson is reportedly in advanced negotiations to acquire medical device maker Guidant Corp. for more than $24 billion.
23990
Shares in J Sainsbury, the supermarkets group, have been surging all week on renewed bid speculation. Yet I think the company has to be believed when it insists that there have been no approaches, nor would